**Special Populations:** Dosage adjustments may be necessary for patients with renal impairment or other underlying health conditions
[DOI] [PubMed] [Google Scholar] 35.Tanaka A., Furubayashi T., Tomisaki M., Kawakami M., Kimura S., Inoue D., Kusamori K., Katsumi H., Sakane T., Yamamoto A
This is considered a favorable alternative to orally bioavailable PDE5 inhibitors that show poor results in subjects with acute metabolic disease [10, 15, 16]
Knowledge Center Henry Schein delivers the solutions health care professionals rely on to improve the performance of their practice so they can improve the lives of patients
Turn the syringe and vial upside down, and draw out the amount needed for your dose